{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T12:40:27Z","timestamp":1791549627221,"version":"4.3.4"},"reference-count":142,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,9,12]],"date-time":"2025-09-12T00:00:00Z","timestamp":1757635200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001321","name":"National Research Foundation","doi-asserted-by":"publisher","award":["CPRR23042899244"],"award-info":[{"award-number":["CPRR23042899244"]}],"id":[{"id":"10.13039\/501100001321","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochemical and Biophysical Research Communications"],"published-print":{"date-parts":[[2025,10]]},"DOI":"10.1016\/j.bbrc.2025.152631","type":"journal-article","created":{"date-parts":[[2025,9,13]],"date-time":"2025-09-13T03:36:08Z","timestamp":1757734568000},"page":"152631","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Targeting phase II detoxification enzyme inhibition in Plasmodium for malaria treatment"],"prefix":"10.1016","volume":"784","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7522-5349","authenticated-orcid":false,"given":"Olalekan","family":"Onisuru","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8658-956X","authenticated-orcid":false,"given":"Ikechukwu","family":"Achilonu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbrc.2025.152631_bib1","series-title":"Global Malaria Programme Operational Strategy 2024-2030","year":"2024"},{"key":"10.1016\/j.bbrc.2025.152631_bib2","series-title":"World Malaria Report 2022","year":"2023"},{"key":"10.1016\/j.bbrc.2025.152631_bib3","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12992-022-00882-w","article-title":"Temporal trends in the burden of non-communicable diseases in countries with the highest malaria burden, 1990\u20132019: evaluating the double burden of non-communicable and communicable diseases in epidemiological transition","volume":"18","author":"Li","year":"2022","journal-title":"Glob. Health"},{"key":"10.1016\/j.bbrc.2025.152631_bib4","doi-asserted-by":"crossref","DOI":"10.1016\/j.parepi.2020.e00187","article-title":"The impact of COVID-19 pandemic on malaria elimination","volume":"11","author":"Zawawi","year":"2020","journal-title":"Parasite Epidemiol. Control."},{"key":"10.1016\/j.bbrc.2025.152631_bib5","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12916-020-01710-x","article-title":"Identifying and combating the impacts of COVID-19 on malaria","volume":"18","author":"Rogerson","year":"2020","journal-title":"BMC Med."},{"key":"10.1016\/j.bbrc.2025.152631_bib6","series-title":"The Potential Impact of Health Service Disruptions on the Burden of Malaria: a Modelling Analysis for Countries in Sub-saharan Africa","first-page":"1","year":"2020"},{"key":"10.1016\/j.bbrc.2025.152631_bib7","doi-asserted-by":"crossref","first-page":"1152","DOI":"10.1016\/j.cmi.2022.03.028","article-title":"Impact of COVID-19 and malaria coinfection on clinical outcomes: a retrospective cohort study","volume":"28","author":"Hussein","year":"2022","journal-title":"Clin. Microbiol. Infect."},{"key":"10.1016\/j.bbrc.2025.152631_bib8","doi-asserted-by":"crossref","DOI":"10.1016\/j.envres.2022.114028","article-title":"Global malaria infection risk from climate change","volume":"214","author":"Li","year":"2022","journal-title":"Environ. Res."},{"key":"10.1016\/j.bbrc.2025.152631_bib9","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/j.actatropica.2018.09.001","article-title":"First detection of Anopheles stephensi Liston, 1901 (Diptera: culicidae) in Ethiopia using molecular and morphological approaches","volume":"188","author":"Carter","year":"2018","journal-title":"Acta Trop."},{"key":"10.1016\/j.bbrc.2025.152631_bib10","first-page":"1","article-title":"Emergence of the invasive malaria vector Anopheles stephensi in Khartoum State, Central Sudan","volume":"14","author":"Ahmed","year":"2021","journal-title":"Parasites Vectors"},{"key":"10.1016\/j.bbrc.2025.152631_bib11","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.actatropica.2014.06.016","article-title":"First record of the Asian malaria vector Anopheles stephensi and its possible role in the resurgence of malaria in Djibouti, Horn of Africa","volume":"139","author":"Faulde","year":"2014","journal-title":"Acta Trop."},{"key":"10.1016\/j.bbrc.2025.152631_bib12","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1146\/annurev-micro-032421-061155","article-title":"Plasmodium vivax latent liver stage infection and relapse: biological insights and new experimental tools","volume":"75","author":"Sch\u00e4fer","year":"2021","journal-title":"Annu. Rev. Microbiol."},{"key":"10.1016\/j.bbrc.2025.152631_bib13","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1016\/j.pt.2020.03.009","article-title":"Plasmodium vivax in the era of the shrinking P. falciparum map","volume":"36","author":"Price","year":"2020","journal-title":"Trends Parasitol."},{"key":"10.1016\/j.bbrc.2025.152631_bib14","series-title":"WHO Malaria Policy Advisory Group (MPAG) Meeting Report, 4, 5 and 7 March 2024","year":"2024"},{"key":"10.1016\/j.bbrc.2025.152631_bib15","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1186\/s12936-025-05305-w","article-title":"Genetic polymorphisms of Plasmodium vivax transmission-blocking vaccine candidates Pvs48\/45 and Pvs47 in Thailand","volume":"24","author":"Kuesap","year":"2025","journal-title":"Malar. J."},{"key":"10.1016\/j.bbrc.2025.152631_bib16","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1186\/1475-2875-13-419","article-title":"The epidemiology of Plasmodium vivax and Plasmodium falciparum malaria in China, 2004-2012: from intensified control to elimination","volume":"13","author":"Zhang","year":"2014","journal-title":"Malar. J."},{"key":"10.1016\/j.bbrc.2025.152631_bib17","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12936-022-04340-1","article-title":"Zero malaria: a mirage or reality for populations of sub-Saharan Africa in health transition","volume":"21","author":"Sarpong","year":"2022","journal-title":"Malar. J."},{"key":"10.1016\/j.bbrc.2025.152631_bib18","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1186\/s40249-023-01110-2","article-title":"What are the pathways between poverty and malaria in sub-Saharan Africa? A systematic review of mediation studies","volume":"12","author":"Wafula","year":"2023","journal-title":"Infect. Dis. Poverty"},{"key":"10.1016\/j.bbrc.2025.152631_bib19","article-title":"Bridging the gap to malaria vaccination in Africa: challenges and opportunities","author":"John","year":"2024","journal-title":"J. Med. Surg. Public Health"},{"key":"10.1016\/j.bbrc.2025.152631_bib20","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12936-019-2995-4","article-title":"The economic burden of malaria on households and the health system in a high transmission district of Mozambique","volume":"18","author":"Alonso","year":"2019","journal-title":"Malar. J."},{"key":"10.1016\/j.bbrc.2025.152631_bib21","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1111\/cbdd.13484","article-title":"Plasmodium falciparum: multidrug resistance","volume":"93","author":"Rout","year":"2019","journal-title":"Chem. Biol. Drug Des."},{"key":"10.1016\/j.bbrc.2025.152631_bib22","doi-asserted-by":"crossref","DOI":"10.1371\/annotation\/0bbd3579-5212-4dcf-a5ef-dd3d8e26f287","article-title":"A systematic in silico search for target similarity identifies several approved drugs with potential activity against the Plasmodium falciparum apicoplast","volume":"8","author":"Bispo","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.bbrc.2025.152631_bib23","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1038\/nrmicro.2017.161","article-title":"Drug resistance in plasmodium","volume":"16","author":"Haldar","year":"2018","journal-title":"Nat. Rev. Microbiol."},{"key":"10.1016\/j.bbrc.2025.152631_bib24","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.ijpddr.2014.02.002","article-title":"Drug repurposing and human parasitic protozoan diseases","volume":"4","author":"Andrews","year":"2014","journal-title":"Int. J. Parasitol. Drugs Drug Resist."},{"key":"10.1016\/j.bbrc.2025.152631_bib25","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1016\/j.pt.2021.01.009","article-title":"MalDA, accelerating malaria drug discovery","volume":"37","author":"Yang","year":"2021","journal-title":"Trends Parasitol."},{"key":"10.1016\/j.bbrc.2025.152631_bib26","doi-asserted-by":"crossref","first-page":"2764","DOI":"10.1021\/acsinfecdis.1c00322","article-title":"Prioritization of molecular targets for antimalarial drug discovery","volume":"7","author":"Forte","year":"2021","journal-title":"ACS Infect. Dis."},{"key":"10.1016\/j.bbrc.2025.152631_bib27","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1038\/nrmicro3183","article-title":"Erratum: antimalarial drug discovery-approaches and progress towards new medicines","volume":"12","author":"Flannery","year":"2014","journal-title":"Nat. Rev. Microbiol."},{"key":"10.1016\/j.bbrc.2025.152631_bib28","doi-asserted-by":"crossref","first-page":"2764","DOI":"10.1021\/acsinfecdis.1c00322","article-title":"Prioritization of molecular targets for antimalarial drug discovery","volume":"7","author":"Forte","year":"2021","journal-title":"ACS Infect. Dis."},{"key":"10.1016\/j.bbrc.2025.152631_bib29","doi-asserted-by":"crossref","first-page":"3875","DOI":"10.2147\/DDDT.S265602","article-title":"Recent progress in the development of new antimalarial drugs with novel targets","volume":"14","author":"Belete","year":"2020","journal-title":"Drug Des. Devel. Ther."},{"key":"10.1016\/j.bbrc.2025.152631_bib30","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/B978-0-323-95328-3.00008-8","article-title":"Antimalarial drugs: discovery, mechanism of action, and drug resistance","author":"Yadav","year":"2024","journal-title":"Falciparum Malar. Diagnostic Tools, Ther. Adv. Futur. Oppor"},{"key":"10.1016\/j.bbrc.2025.152631_bib31","doi-asserted-by":"crossref","first-page":"1300","DOI":"10.1016\/j.ejmech.2016.11.025","article-title":"Comprehensive review on various strategies for antimalarial drug discovery","volume":"125","author":"Mishra","year":"2017","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bbrc.2025.152631_bib32","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1039\/C7MD00637C","article-title":"Recent updates in the discovery and development of novel antimalarial drug candidates","volume":"9","author":"Okombo","year":"2018","journal-title":"Medchemcomm"},{"key":"10.1016\/j.bbrc.2025.152631_bib33","doi-asserted-by":"crossref","DOI":"10.1016\/j.bmc.2023.117339","article-title":"Recent developments in antimalarial drug discovery","author":"Umumararungu","year":"2023","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.bbrc.2025.152631_bib34","first-page":"1","article-title":"Repurposing drugs to target the malaria parasite unfolding protein response","volume":"8","author":"Chen","year":"2018","journal-title":"Sci. Rep."},{"key":"10.1016\/j.bbrc.2025.152631_bib35","doi-asserted-by":"crossref","first-page":"2192","DOI":"10.1002\/cmdc.202100176","article-title":"Repurposing anticancer drugs to tackle malaria","volume":"16","author":"Le Govic","year":"2021","journal-title":"ChemMedChem"},{"key":"10.1016\/j.bbrc.2025.152631_bib36","series-title":"Pharmacology of Antimalarial Drugs, Current Anti-malarials, Encycl. Malaria","first-page":"1","author":"Na-Bangchang","year":"2019"},{"key":"10.1016\/j.bbrc.2025.152631_bib37","doi-asserted-by":"crossref","first-page":"4047","DOI":"10.2147\/IDR.S279433","article-title":"Antimalarial drug resistance and novel targets for antimalarial drug discovery","volume":"13","author":"Shibeshi","year":"2020","journal-title":"Infect. Drug Resist."},{"key":"10.1016\/j.bbrc.2025.152631_bib38","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1016\/j.ijpddr.2016.09.004","article-title":"Exploring the scope of new arylamino alcohol derivatives: synthesis, antimalarial evaluation, toxicological studies, and target exploration","volume":"6","author":"Quiliano","year":"2016","journal-title":"Int. J. Parasitol. Drugs Drug Resist."},{"key":"10.1016\/j.bbrc.2025.152631_bib39","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2020.112955","article-title":"An insight into the recent development of the clinical candidates for the treatment of malaria and their target proteins","volume":"210","author":"Madhav","year":"2021","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bbrc.2025.152631_bib40","doi-asserted-by":"crossref","DOI":"10.1128\/aac.01538-21","article-title":"New insights into antimalarial chemopreventive activity of antifolates","volume":"66","author":"Pethrak","year":"2022","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.bbrc.2025.152631_bib41","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1475-2875-9-247","article-title":"Anti-folate drug resistance in Africa: meta-analysis of reported dihydrofolate reductase (dhfr) and dihydropteroate synthase (dhps) mutant genotype frequencies in African Plasmodium falciparum parasite populations","volume":"9","author":"Sridaran","year":"2010","journal-title":"Malar. J."},{"key":"10.1016\/j.bbrc.2025.152631_bib42","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1111\/nyas.12662","article-title":"The molecular basis of antifolate resistance in Plasmodium falciparum: looking beyond point mutations","volume":"1342","author":"Heinberg","year":"2015","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.bbrc.2025.152631_bib43","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.biopha.2018.05.009","article-title":"Drug targets for resistant malaria: historic to future perspectives","volume":"104","author":"Kumar","year":"2018","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.bbrc.2025.152631_bib44","doi-asserted-by":"crossref","first-page":"5748","DOI":"10.3390\/ijms20225748","article-title":"An overview of drug resistance in protozoal diseases","volume":"20","author":"Capela","year":"2019","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.bbrc.2025.152631_bib45","doi-asserted-by":"crossref","first-page":"1427","DOI":"10.1016\/j.ijpara.2006.07.011","article-title":"Current perspectives on the mechanism of action of artemisinins","volume":"36","author":"Golenser","year":"2006","journal-title":"Int. J. Parasitol."},{"key":"10.1016\/j.bbrc.2025.152631_bib46","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1371\/journal.pone.0225882","article-title":"Efficacy of antimalarial drugs for treatment of uncomplicated falciparum malaria in Asian region: a network meta-analysis","volume":"14","author":"Naing","year":"2019","journal-title":"PLoS One"},{"key":"10.1016\/j.bbrc.2025.152631_bib47","first-page":"1599","volume":"6","author":"Rosenthal","year":"2020"},{"key":"10.1016\/j.bbrc.2025.152631_bib48","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1002\/ddr.20345","article-title":"Next\u2010generation antimalarial drugs: hybrid molecules as a new strategy in drug design","volume":"71","author":"Muregi","year":"2010","journal-title":"Drug Dev. Res."},{"key":"10.1016\/j.bbrc.2025.152631_bib49","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2019.111983","article-title":"Current progress in antimalarial pharmacotherapy and multi-target drug discovery","volume":"188","author":"Tibon","year":"2020","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bbrc.2025.152631_bib50","doi-asserted-by":"crossref","first-page":"4436","DOI":"10.1039\/D2RA07977A","article-title":"Marine organisms as potential sources of natural products for the prevention and treatment of malaria","volume":"13","author":"Negm","year":"2023","journal-title":"RSC Adv."},{"key":"10.1016\/j.bbrc.2025.152631_bib51","doi-asserted-by":"crossref","first-page":"134","DOI":"10.3390\/md19030134","article-title":"Metabolites from marine sponges and their potential to treat malarial Protozoan parasites infection: a systematic review","volume":"19","author":"Aguiar","year":"2021","journal-title":"Mar. Drugs"},{"key":"10.1016\/j.bbrc.2025.152631_bib52","doi-asserted-by":"crossref","first-page":"187","DOI":"10.3390\/md18040187","article-title":"Screening marine natural products for new drug leads against trypanosomatids and malaria","volume":"18","author":"\u00c1lvarez-Bard\u00f3n","year":"2020","journal-title":"Mar. Drugs"},{"key":"10.1016\/j.bbrc.2025.152631_bib53","first-page":"423","volume":"120","author":"Tiwari","year":"2021"},{"key":"10.1016\/j.bbrc.2025.152631_bib54","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1038\/s41573-023-00772-9","article-title":"Antimalarial drug discovery: progress and approaches","volume":"22","author":"Siqueira-Neto","year":"2023","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.bbrc.2025.152631_bib55","first-page":"1","article-title":"New developments in anti-malarial target candidate and product profiles","volume":"16","author":"Burrows","year":"2017","journal-title":"Malar. J."},{"key":"10.1016\/j.bbrc.2025.152631_bib56","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.tibs.2021.10.006","article-title":"Structural parasitology of the malaria parasite Plasmodium falciparum","volume":"47","author":"Anton","year":"2022","journal-title":"Trends Biochem. Sci."},{"key":"10.1016\/j.bbrc.2025.152631_bib57","doi-asserted-by":"crossref","first-page":"26","DOI":"10.11606\/issn.1984-5154.v6p26-31","article-title":"Antigenic diversity and immune evasion in malaria parasites","volume":"6","author":"Ferreira","year":"2011","journal-title":"Rev. da Biol."},{"key":"10.1016\/j.bbrc.2025.152631_bib58","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1016\/j.mib.2012.03.003","article-title":"Antigenic variation and the generation of diversity in malaria parasites","volume":"15","author":"Kirkman","year":"2012","journal-title":"Curr. Opin. Microbiol."},{"key":"10.1016\/j.bbrc.2025.152631_bib59","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1097\/MOH.0000000000000135","article-title":"Host\u2013parasite interactions that guide red blood cell invasion by malaria parasites","volume":"22","author":"Paul","year":"2015","journal-title":"Curr. Opin. Hematol."},{"key":"10.1016\/j.bbrc.2025.152631_bib60","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1093\/femsre\/fuz005","article-title":"Targeting malaria parasite invasion of red blood cells as an antimalarial strategy","volume":"43","author":"Burns","year":"2019","journal-title":"FEMS Microbiol. Rev."},{"key":"10.1016\/j.bbrc.2025.152631_bib61","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1016\/j.pt.2021.12.005","article-title":"RBC membrane biomechanics and Plasmodium falciparum invasion: probing beyond ligand\u2013receptor interactions","volume":"38","author":"Groomes","year":"2022","journal-title":"Trends Parasitol."},{"key":"10.1016\/j.bbrc.2025.152631_bib62","doi-asserted-by":"crossref","first-page":"1715","DOI":"10.1007\/s00436-023-07868-6","article-title":"Escaping the enemy's bullets: an update on how malaria parasites evade host immune response","volume":"122","author":"Ezema","year":"2023","journal-title":"Parasitol. Res."},{"key":"10.1016\/j.bbrc.2025.152631_bib63","doi-asserted-by":"crossref","first-page":"1362","DOI":"10.1086\/656476","article-title":"Artemisinin-induced dormancy in Plasmodium falciparum: duration, recovery rates, and implications in treatment failure","volume":"202","author":"Teuscher","year":"2010","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.bbrc.2025.152631_bib64","doi-asserted-by":"crossref","first-page":"1872","DOI":"10.1128\/AAC.01636-09","article-title":"Increased tolerance to artemisinin in Plasmodium falciparum is mediated by a quiescence mechanism","volume":"54","author":"Witkowski","year":"2010","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.bbrc.2025.152631_bib65","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1186\/s12936-016-1206-9","article-title":"Plasmodium falciparum: multifaceted resistance to artemisinins","volume":"15","author":"Paloque","year":"2016","journal-title":"Malar. J."},{"key":"10.1016\/j.bbrc.2025.152631_bib66","article-title":"Antimalarial drug resistance: a threat to malaria elimination, Cold Spring Harb","volume":"7","author":"Menard","year":"2017","journal-title":"Perspect. Med."},{"key":"10.1016\/j.bbrc.2025.152631_bib67","doi-asserted-by":"crossref","DOI":"10.1038\/nrdp.2017.50","article-title":"Malaria","volume":"3","author":"Phillips","year":"2017","journal-title":"Nat. Rev. Dis. Primers"},{"key":"10.1016\/j.bbrc.2025.152631_bib68","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1007\/s11908-010-0099-y","article-title":"Drug-resistant malaria: the era of ACT, Curr","volume":"12","author":"Lin","year":"2010","journal-title":"Infect. Dis. Rep."},{"key":"10.1016\/j.bbrc.2025.152631_bib69","doi-asserted-by":"crossref","first-page":"62","DOI":"10.4269\/ajtmh.16-0180","article-title":"Key knowledge gaps for Plasmodium vivax control and elimination","volume":"95","author":"Bassat","year":"2016","journal-title":"Am. J. Trop. Med. Hyg."},{"key":"10.1016\/j.bbrc.2025.152631_bib70","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/antiox10121872","article-title":"Reactive oxygen species as the brainbox in malaria treatment","volume":"10","author":"Egwu","year":"2021","journal-title":"Antioxidants"},{"key":"10.1016\/j.bbrc.2025.152631_bib71","first-page":"1","article-title":"Progeny counter mechanism in malaria parasites is linked to extracellular resources","volume":"19","author":"Stuermer","year":"2023","journal-title":"bioRxiv"},{"key":"10.1016\/j.bbrc.2025.152631_bib72","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.abj5362","article-title":"Asynchronous nuclear cycles in multinucleated Plasmodium falciparum facilitate rapid proliferation","volume":"8","author":"Klaus","year":"2022","journal-title":"Sci. Adv."},{"key":"10.1016\/j.bbrc.2025.152631_bib73","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2022.114653","article-title":"New structural classes of antimalarials","volume":"242","author":"Rathod","year":"2022","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bbrc.2025.152631_bib74","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1017\/S0031182021002134","article-title":"Current status of experimental models for the study of malaria","volume":"149","author":"Simwela","year":"2022","journal-title":"Parasitology"},{"key":"10.1016\/j.bbrc.2025.152631_bib75","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1186\/s12936-017-1860-6","article-title":"Within-host selection of drug resistance in a mouse model of repeated interrupted treatment of Plasmodium yoelii infection","volume":"16","author":"Nuralitha","year":"2017","journal-title":"Malar. J."},{"key":"10.1016\/j.bbrc.2025.152631_bib76","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1128\/AAC.44.2.344-347.2000","article-title":"Mechanisms of artemisinin resistance in the rodent malaria pathogen Plasmodium yoelii, Antimicrob","volume":"44","author":"Walker","year":"2000","journal-title":"Agents Chemother"},{"key":"10.1016\/j.bbrc.2025.152631_bib77","doi-asserted-by":"crossref","first-page":"2042","DOI":"10.1128\/AAC.01677-08","article-title":"Dynamics of malaria drug resistance patterns in the Amazon basin region following changes in Peruvian national treatment policy for uncomplicated malaria, Antimicrob","volume":"53","author":"Bacon","year":"2009","journal-title":"Agents Chemother."},{"key":"10.1016\/j.bbrc.2025.152631_bib78","doi-asserted-by":"crossref","first-page":"1455","DOI":"10.1017\/S0031182013000954","article-title":"Genetic and genomic approaches for the discovery of parasite genes involved in antimalarial drug resistance","volume":"140","author":"Mwangi","year":"2013","journal-title":"Parasitology"},{"key":"10.1016\/j.bbrc.2025.152631_bib79","doi-asserted-by":"crossref","first-page":"2569","DOI":"10.1111\/febs.14127","article-title":"Combating multidrug-resistant Plasmodium falciparum malaria","volume":"284","author":"Thu","year":"2017","journal-title":"FEBS J."},{"key":"10.1016\/j.bbrc.2025.152631_bib80","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1586\/14787210.2016.1106938","article-title":"Plasmodium falciparum kelch 13: a potential molecular marker for tackling artemisinin-resistant malaria parasites","volume":"14","author":"Mita","year":"2016","journal-title":"Expert Rev. Anti Infect. Ther."},{"key":"10.1016\/j.bbrc.2025.152631_bib81","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.jgar.2015.02.002","article-title":"Resistance to antimalarial drugs: an endless world war against Plasmodium that we risk losing","volume":"3","author":"Severini","year":"2015","journal-title":"J. Glob. Antimicrob. Resist."},{"key":"10.1016\/j.bbrc.2025.152631_bib82","series-title":"Antimalarial Drug Combination Therapy: Report of a WHO Technical Consultation, 4\u20135 April, 2001","year":"2001"},{"key":"10.1016\/j.bbrc.2025.152631_bib83","doi-asserted-by":"crossref","first-page":"641","DOI":"10.4269\/ajtmh.2007.76.641","article-title":"PFMDR1 and in vivo resistance to artesunate-mefloquine in falciparum malaria on the Cambodian-Thai border","volume":"76","author":"Alker","year":"2007","journal-title":"Am. J. Trop. Med. Hyg."},{"key":"10.1016\/j.bbrc.2025.152631_bib84","doi-asserted-by":"crossref","first-page":"2619","DOI":"10.1056\/NEJMc0805011","article-title":"Evidence of artemisinin-resistant malaria in Western Cambodia","volume":"359","author":"Noedl","year":"2008","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.bbrc.2025.152631_bib85","first-page":"1","article-title":"Review of malaria vaccine clinical development","year":"2024","journal-title":"World Heal. Organ."},{"key":"10.1016\/j.bbrc.2025.152631_bib86","doi-asserted-by":"crossref","first-page":"149","DOI":"10.17712\/1658-3183.2698","article-title":"WHO prequalifies a second malaria vaccine, a significant milestone in prevention of the disease","volume":"29","year":"2024","journal-title":"Neurosciences"},{"key":"10.1016\/j.bbrc.2025.152631_bib87","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fimmu.2017.00349","article-title":"Signaling strategies of malaria parasite for its survival, proliferation, and infection during erythrocytic stage","volume":"8","author":"Soni","year":"2017","journal-title":"Front. Immunol."},{"key":"10.1016\/j.bbrc.2025.152631_bib88","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1515\/BC.2003.063","article-title":"Glutathione--functions and metabolism in the malarial parasite Plasmodium falciparum","volume":"384","author":"Becker","year":"2003","journal-title":"Biol. Chem."},{"key":"10.1016\/j.bbrc.2025.152631_bib89","doi-asserted-by":"crossref","first-page":"1547","DOI":"10.1002\/prot.26333","article-title":"Characterization of glutamate\u2010cysteine ligase and glutathione synthetase from the \u03b4\u2010proteobacterium Myxococcus xanthus","volume":"90","author":"Okada","year":"2022","journal-title":"Proteins: Struct., Funct., Bioinf."},{"key":"10.1016\/j.bbrc.2025.152631_bib90","doi-asserted-by":"crossref","first-page":"3143","DOI":"10.1016\/j.bbagen.2012.09.008","article-title":"Glutathione synthesis","volume":"1830","author":"Lu","year":"2013","journal-title":"Biochim. Biophys. Acta - Gen. Subj."},{"key":"10.1016\/j.bbrc.2025.152631_bib91","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/j.ijmm.2012.07.007","article-title":"Thioredoxin and glutathione systems in Plasmodium falciparum","volume":"302","author":"Jortzik","year":"2012","journal-title":"Int. J. Med. Microbiol."},{"key":"10.1016\/j.bbrc.2025.152631_bib92","doi-asserted-by":"crossref","first-page":"10511","DOI":"10.3390\/molecules200610511","article-title":"Role and regulation of glutathione metabolism in plasmodium falciparum","volume":"20","author":"M\u00fcller","year":"2015","journal-title":"Molecules"},{"key":"10.1016\/j.bbrc.2025.152631_bib93","doi-asserted-by":"crossref","DOI":"10.1016\/j.pestbp.2021.104880","article-title":"The roles of GSTs in fipronil resistance in Nilaparvata lugens : over-expression and expression induction","volume":"177","author":"Gao","year":"2021","journal-title":"Pestic. Biochem. Physiol."},{"key":"10.1016\/j.bbrc.2025.152631_bib94","doi-asserted-by":"crossref","first-page":"149","DOI":"10.5958\/2320-3188.2022.00018.3","article-title":"Oxidative stress in Plasmodium: role of glutathione revisited","volume":"41","author":"Kapoor","year":"2022","journal-title":"Bull. Pure Appl. Sci."},{"key":"10.1016\/j.bbrc.2025.152631_bib95","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.cois.2018.04.007","article-title":"The role of glutathione S-transferases (GSTs) in insecticide resistance in crop pests and disease vectors","volume":"27","author":"Pavlidi","year":"2018","journal-title":"Curr. Opin. Insect Sci."},{"key":"10.1016\/j.bbrc.2025.152631_bib96","first-page":"778","author":"Hilario","year":"2020"},{"key":"10.1016\/j.bbrc.2025.152631_bib97","doi-asserted-by":"crossref","first-page":"13821","DOI":"10.1073\/pnas.2333763100","article-title":"X-ray structure of glutathione S-transferase from the malarial parasite Plasmodium falciparum","volume":"100","author":"Fritz-Wolf","year":"2003","journal-title":"Proc. Natl. Acad. Sci. U. S. A"},{"key":"10.1016\/j.bbrc.2025.152631_bib98","doi-asserted-by":"crossref","DOI":"10.1155\/2021\/9135617","article-title":"The potential use of a curcumin-piperine combination as an antimalarial agent: a systematic review","volume":"2021","author":"Khairani","year":"2021","journal-title":"J. Trop. Med."},{"key":"10.1016\/j.bbrc.2025.152631_bib99","doi-asserted-by":"crossref","first-page":"854","DOI":"10.3109\/14756366.2010.486793","article-title":"Glutathione transferase from Plasmodium falciparum - interaction with malagashanine and selected plant natural products","volume":"25","author":"Mangoyi","year":"2010","journal-title":"J. Enzym. Inhib. Med. Chem."},{"key":"10.1016\/j.bbrc.2025.152631_bib100","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1472-6807-6-20","article-title":"The crystal structure of superoxide dismutase from Plasmodium falciparum","volume":"6","author":"Boucher","year":"2006","journal-title":"BMC Struct. Biol."},{"key":"10.1016\/j.bbrc.2025.152631_bib101","doi-asserted-by":"crossref","first-page":"S51","DOI":"10.1016\/S2222-1808(15)60856-8","article-title":"Superoxide dismutase activity in patients of cerebral malaria","volume":"5","author":"Raza","year":"2015","journal-title":"Asian Pacific J. Trop. Dis."},{"key":"10.1016\/j.bbrc.2025.152631_bib102","doi-asserted-by":"crossref","first-page":"11459","DOI":"10.3390\/molecules200611459","article-title":"Plasmodium falciparum thioredoxin reductase (PfTrxR) and its role as a target for new antimalarial discovery","volume":"20","author":"McCarty","year":"2015","journal-title":"Molecules"},{"key":"10.1016\/j.bbrc.2025.152631_bib103","doi-asserted-by":"crossref","first-page":"40180","DOI":"10.1074\/jbc.M007633200","article-title":"The thioredoxin system of the malaria parasite Plasmodium falciparum","volume":"275","author":"Kanzok","year":"2000","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbrc.2025.152631_bib104","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1016\/S0022-2836(03)00347-4","article-title":"Glutathione reductase of the malarial parasite Plasmodium falciparum: crystal structure and inhibitor development","volume":"328","author":"Sarma","year":"2003","journal-title":"J. Mol. Biol."},{"key":"10.1016\/j.bbrc.2025.152631_bib105","doi-asserted-by":"crossref","first-page":"351a","DOI":"10.1016\/j.bpj.2016.11.1903","article-title":"The binding of methylene blue to plasmodium falciparum glutathione reductase","volume":"112","author":"Prieto","year":"2017","journal-title":"Biophys. J."},{"key":"10.1016\/j.bbrc.2025.152631_bib106","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fphar.2020.00246","article-title":"Structure-based screening of plasmodium berghei glutathione S-transferase identifies CB-27 as a novel antiplasmodial compound","volume":"11","author":"Col\u00f3n-Lorenzo","year":"2020","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.bbrc.2025.152631_bib107","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.biochi.2017.01.005","article-title":"Insights into ligand binding to a glutathione S-transferase from mango: structure, thermodynamics and kinetics","volume":"135","author":"Valenzuela-Chavira","year":"2017","journal-title":"Biochimie"},{"key":"10.1016\/j.bbrc.2025.152631_bib108","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1016\/j.exppara.2007.02.005","article-title":"Plasmodium vivax: molecular cloning, expression and characterization of glutathione S-transferase","volume":"116","author":"Na","year":"2007","journal-title":"Exp. Parasitol."},{"key":"10.1016\/j.bbrc.2025.152631_bib109","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.abb.2009.05.011","article-title":"Structural, functional and unfolding characteristics of glutathione S-transferase of Plasmodium vivax","volume":"487","author":"Tripathi","year":"2009","journal-title":"Arch. Biochem. Biophys."},{"key":"10.1016\/j.bbrc.2025.152631_bib110","doi-asserted-by":"crossref","first-page":"D539","DOI":"10.1093\/nar\/gkn814","article-title":"PlasmoDB: a functional genomic database for malaria parasites","volume":"37","author":"Aurrecoechea","year":"2009","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.bbrc.2025.152631_bib111","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1002\/9783527630905.ch10","article-title":"Introduction to drug metabolism, metab","author":"Zanger","year":"2012","journal-title":"Drugs Other Xenobiotics"},{"key":"10.1016\/j.bbrc.2025.152631_bib112","author":"Phang-Lyn"},{"key":"10.1016\/j.bbrc.2025.152631_bib113","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1016\/j.pt.2016.02.004","article-title":"The role of xenobiotic-metabolizing enzymes in anthelmintic deactivation and resistance in helminths","volume":"32","author":"Matou\u0161kov\u00e1","year":"2016","journal-title":"Trends Parasitol."},{"key":"10.1016\/j.bbrc.2025.152631_bib114","doi-asserted-by":"crossref","DOI":"10.1016\/j.isci.2020.101487","article-title":"Mechanism of action and target identification: a matter of timing in drug discovery","volume":"23","author":"Davis","year":"2020","journal-title":"iScience"},{"key":"10.1016\/j.bbrc.2025.152631_bib115","doi-asserted-by":"crossref","first-page":"2067","DOI":"10.1042\/BST20200224","article-title":"Driving antimalarial design through understanding of target mechanism","volume":"48","author":"Calic","year":"2020","journal-title":"Biochem. Soc. Trans."},{"key":"10.1016\/j.bbrc.2025.152631_bib116","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1080\/17460441.2020.1691996","article-title":"New directions in antimalarial target validation","volume":"15","author":"Batista","year":"2020","journal-title":"Expet Opin. Drug Discov."},{"key":"10.1016\/j.bbrc.2025.152631_bib117","doi-asserted-by":"crossref","first-page":"D1113","DOI":"10.1093\/nar\/gkt1246","article-title":"The Transformer database: biotransformation of xenobiotics","volume":"42","author":"Hoffmann","year":"2014","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.bbrc.2025.152631_bib118","series-title":"Fundamentals of Toxicology: Essential Concepts and Applications","author":"Gupta","year":"2016"},{"key":"10.1016\/j.bbrc.2025.152631_bib119","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0008649","article-title":"Drug metabolism and pharmacokinetics of praziquantel: a review of variable drug exposure during schistosomiasis treatment in human hosts and experimental models","volume":"14","author":"Zdesenko","year":"2020","journal-title":"PLoS Negl. Trop. Dis."},{"key":"10.1016\/j.bbrc.2025.152631_bib120","series-title":"Basic & Clinical Pharmacology: Drug Biotransformation","author":"Correia","year":"2018"},{"key":"10.1016\/j.bbrc.2025.152631_bib121","series-title":"Pharm. Biocatal.","first-page":"129","article-title":"Biotransformation of xenobiotics in living systems\u2014metabolism of drugs: partnership of liver and gut microflora","author":"\u0110ani\u0107","year":"2020"},{"key":"10.1016\/j.bbrc.2025.152631_bib122","series-title":"Textbook of Biochemistry for Medical Students","author":"Vaidyanathan","year":"2016"},{"key":"10.1016\/j.bbrc.2025.152631_bib123","first-page":"84","article-title":"The effect of some antimalarial drugs on Plasmodium berghei glutathione-S-transferase enzyme","volume":"12","author":"Sadeghi Tafreshi","year":"2019","journal-title":"J. Microb. World."},{"key":"10.1016\/j.bbrc.2025.152631_bib124","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1016\/j.ibmb.2005.03.008","article-title":"Elevated activity of an Epsilon class glutathione transferase confers DDT resistance in the dengue vector, Aedes aegypti","volume":"35","author":"Lumjuan","year":"2005","journal-title":"Insect Biochem. Mol. Biol."},{"key":"10.1016\/j.bbrc.2025.152631_bib125","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1179\/135100003225002907","article-title":"Glutathione is involved in the antimalarial action of chloroquine and its modulation affects drug sensitivity of human and murine species of Plasmodium","volume":"8","author":"Ginsburg","year":"2003","journal-title":"Redox Rep."},{"key":"10.1016\/j.bbrc.2025.152631_bib126","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.ijpddr.2011.11.001","article-title":"Degrees of chloroquine resistance in Plasmodium\u2013Is the redox system involved?","volume":"2","author":"Lehane","year":"2012","journal-title":"Int. J. Parasitol. Drugs Drug Resist."},{"key":"10.1016\/j.bbrc.2025.152631_bib127","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12936-017-1831-y","article-title":"Increase in the prevalence of mutations associated with sulfadoxine-pyrimethamine resistance in Plasmodium falciparum isolates collected from early to late pregnancy in Nanoro, Burkina Faso","volume":"16","author":"Ruizendaal","year":"2017","journal-title":"Malar. J."},{"key":"10.1016\/j.bbrc.2025.152631_bib128","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1093\/cid\/civ881","article-title":"Impact of sulfadoxine-pyrimethamine resistance on effectiveness of intermittent preventive therapy for Malaria in pregnancy at clearing infections and preventing low birth weight","volume":"62","author":"Desai","year":"2016","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.bbrc.2025.152631_bib129","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1111\/j.1365-2958.2012.08180.x","article-title":"Mechanisms of in vitro resistance to dihydroartemisinin in Plasmodium falciparum","volume":"86","author":"Cui","year":"2012","journal-title":"Mol. Microbiol."},{"key":"10.1016\/j.bbrc.2025.152631_bib130","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41598-017-06650-w","article-title":"Unraveling heme detoxification in the malaria parasite by in situ correlative X-ray fluorescence microscopy and soft X-ray tomography","volume":"7","author":"Kapishnikov","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.bbrc.2025.152631_bib131","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.biopha.2021.112302","article-title":"Inhibition of heme detoxification pathway in malaria parasite by 3-hydroxy-11-keto-\u03b2-boswellic acid isolated from Boswellia serrata","volume":"144","author":"Gupta","year":"2021","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.bbrc.2025.152631_bib132","doi-asserted-by":"crossref","first-page":"3383","DOI":"10.3390\/ijms24043383","article-title":"Human cytochrome P450 1, 2, 3 families as pharmacogenes with emphases on their antimalarial and antituberculosis drugs and prevalent African alleles","volume":"24","author":"Chamboko","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.bbrc.2025.152631_bib133","doi-asserted-by":"crossref","DOI":"10.1016\/j.jorganchem.2021.122154","article-title":"Metabolism of 8-aminoquinoline (8AQ) primaquine via aromatic hydroxylation step mediated by cytochrome P450 enzyme using density functional theory","volume":"957","author":"Awasthi","year":"2022","journal-title":"J. Organomet. Chem."},{"key":"10.1016\/j.bbrc.2025.152631_bib134","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1110\/ps.051891106","article-title":"Plasmodium falciparum glutathione S -transferase-Structural and mechanistic studies on ligand binding and enzyme inhibition","volume":"15","author":"Hiller","year":"2006","journal-title":"Protein Sci."},{"key":"10.1016\/j.bbrc.2025.152631_bib135","doi-asserted-by":"crossref","first-page":"26121","DOI":"10.1074\/jbc.M503889200","article-title":"Cooperativity and pseudo-cooperativity in the glutathione S-transferase from Plasmodium falciparum","volume":"280","author":"Liebau","year":"2005","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbrc.2025.152631_bib136","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1016\/j.jsb.2015.06.008","article-title":"High resolution structures of Plasmodium falciparum GST complexes provide novel insights into the dimer\u2013tetramer transition and a novel ligand-binding site","volume":"191","author":"Perbandt","year":"2015","journal-title":"J. Struct. Biol."},{"key":"10.1016\/j.bbrc.2025.152631_bib137","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1007\/s00894-023-05650-0","article-title":"Development and application of fragment-based de novo inhibitor design approaches against Plasmodium falciparum GST","volume":"29","author":"Al-Qattan","year":"2023","journal-title":"J. Mol. Model."},{"key":"10.1016\/j.bbrc.2025.152631_bib138","article-title":"Exploring the infectious drug target glutathione S-transferase in plasmodium falciparum with the inhibitory potential of Azadirachta indica phytocompounds","volume":"2024","author":"Al-Malki","year":"2024","journal-title":"Adv. Public Heal."},{"key":"10.1016\/j.bbrc.2025.152631_bib139","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ijbiomac.2025.140526","article-title":"High-throughput virtual screening and empirical validation of probable inhibitors of Plasmodium falciparum and vivax glutathione transferase using bromosulfophthalein as the benchmark ligand","volume":"302","author":"Onisuru","year":"2025","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.bbrc.2025.152631_bib140","first-page":"1","article-title":"Describing the ligandin properties of Plasmodium falciparum and vivax glutathione transferase towards bromosulfophthalein from empirical and computational modelling viewpoints","author":"Onisuru","year":"2024","journal-title":"J. Biomol. Struct. Dyn."},{"key":"10.1016\/j.bbrc.2025.152631_bib141","doi-asserted-by":"crossref","DOI":"10.1016\/j.cmi.2025.03.009","article-title":"The non-artemisinin antimalarial drugs under development: a review","author":"Okwu","year":"2025","journal-title":"Clin. Microbiol. Infect."},{"key":"10.1016\/j.bbrc.2025.152631_bib142","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1110\/ps.051891106","article-title":"Plasmodium falciparum glutathione S \u2010transferase\u2014structural and mechanistic studies on ligand binding and enzyme inhibition","volume":"15","author":"Hiller","year":"2006","journal-title":"Protein Sci."}],"container-title":["Biochemical and Biophysical Research Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006291X25013476?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006291X25013476?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T08:33:44Z","timestamp":1780302824000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006291X25013476"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10]]},"references-count":142,"alternative-id":["S0006291X25013476"],"URL":"https:\/\/doi.org\/10.1016\/j.bbrc.2025.152631","relation":{},"ISSN":["0006-291X"],"issn-type":[{"value":"0006-291X","type":"print"}],"subject":[],"published":{"date-parts":[[2025,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Targeting phase II detoxification enzyme inhibition in Plasmodium for malaria treatment","name":"articletitle","label":"Article Title"},{"value":"Biochemical and Biophysical Research Communications","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbrc.2025.152631","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"152631"}}